Kymera Therapeutics Inc

NASDAQ:KYMR   3:59:50 PM EDT
15.01
+0.78 (+5.48%)
Earnings Announcements

Kymera Therapeutics Announces First Quarter 2022 Results

Published: 05/03/2022 12:34 GMT
Kymera Therapeutics Inc (KYMR) - Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update.
Qtrly Loss per Share $0.71.
Q1 Earnings per Share View $-0.66, Revenue View $16.2 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $14.67 Million
Adjusted EPS is expected to be -$0.68

Next Quarter Revenue Guidance is expected to be $22.6 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.